 |
| Michael Pragnell |
Our performance in 2004 reflects the strong foundation we have been building since the companys creation and the immense commitment of our people worldwide. All businesses performed well as they capitalized on the opportunities presented by recovering agricultural markets. Our sustained emphasis on cost and capital efficiency contributed to significant earnings growth and substantially enhanced returns
As we enter a new phase with the merger successfully behind us, our strategy
has three main elements: to enhance leadership in Crop Protection and Field
Crops Seeds; to drive growth in the consumer-led areas of Professional Products
and Vegetables and Flower Seeds; and to create new opportunities by exploiting
our Plant Science capabilities. Progress was marked in all three as we continue
to build on the firm foundation
we have created and our promising R&D pipeline.
Crop Protection growth was notably high in Latin America. Our leading brands,
combined with excellent local marketing, also enabled us to expand sales in
Eastern Europe and parts of Asia whilst taking full advantage of better conditions
in Western Europe. New products again grew strongly. In particular, growth
in the ACTARA, AMISTAR and CALLISTO® families
enhanced Syngentas leadership in many markets.
In Field Crops, the acquisition of GARST and GOLDEN
HARVEST substantially strengthened our position in US corn and soybean seeds,
creating a broad platform for trait commercialization. In cotton, we entered
a long-term technology agreement with the US market
leader, Delta & Pine Land Company.
Professional Products and Vegetables and Flower Seeds maintained their five
year record of consistent
growth thanks to sustained product innovation.
In the consumer-led fresh produce market we are developing new business models,
and Dulcinea Farms in the USA continues to demonstrate promise. Progress in
the animal feed market was slower than expected due to unanticipated delays
in the US registration of
QUANTUM Phytase. Longer-term developments in enzymes and biopharmaceuticals
look promising.
None of the many achievements of last year would have been possible without
the support of our customers to whom I extend my thanks. This support reflects
the dedication of our employees worldwide whose energy and enthusiasm remain
unflagging: to them my
warmest appreciation.
Our confidence in our people, and their ability to innovate and exploit our
broad portfolio and commercial reach, leads us to re-affirm our target of high-teens
growth in earnings per share in each of the next two years. It also enables
us to increase our three year cash return program to shareholders to more than
$1 billion
by end 2006.
At the end of 2004, Jeff Beard stepped down from the Executive Committee.
I would like to thank him as COO Seeds since merger for his professionalism
and his contribution to our progress. He is succeeded by Mike Mack who joined
Syngenta in 2002 as Head of
Crop Protection NAFTA.
We remain fully committed to enhancing value for shareholders as we continue
to reinforce leadership in our core businesses and drive growth. Our goal is
to build an enterprise of which employees, customers and shareholders alike
can be truly proud.
|